🇺🇸 FDA
Pipeline program

JNJ-67896062, JNJ-67896062

AC-055-312

Phase 3 small_molecule active

Quick answer

JNJ-67896062, JNJ-67896062 for Pediatric pulmonary arterial hypertension is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Pharma Mar S.A.
Indication
Pediatric pulmonary arterial hypertension
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials